Lyell Immunopharma, Inc.’s LYEL share price has surged by 20.28%, which has investors questioning if this is right time to ...

肝脏中miR-181d-5p的过表达与肢体缺血预处理通过抑制核受体4A3（NR4A3）所产生的分子和组织学益处一致。此外，来自接受肢体缺血预处理的人类志愿者的循环细胞外囊泡（EVs）在原代人类肝细胞和动物模型中改善了脂肪性肝炎和转录组的紊乱。这些数据强调了肢体 ...

撰文丨王聪编辑丨王多鱼排版丨水成文代谢功能障碍相关脂肪性肝炎（MASH）是一种晚期肝脏疾病，预后不良。调控器官间的信息交流被认为是一种很有前景的策略，可用于治疗代谢性疾病，包括脂肪性肝炎。2025 年 3 月 20 ...

Equities research analysts at HC Wainwright boosted their Q1 2025 earnings per share (EPS) estimates for Lyell Immunopharma in a research note issued on Thursday, March 13th. HC Wainwright analyst M.

After hours: March 26 at 7:06:55 PM EDT Loading Chart for LYEL ...

Mounting evidence indicates that nuclear receptors play a critical regulatory role in platelet pathophysiology and thrombotic disorders. Although NR4A (the nuclear receptor subfamily 4 group A) plays ...

研究团队进一步验证了在肝脏中 miR-181d-5p 的过表达通过抑制核受体 4A3（NR4A3）准确地反映了肢体缺血预处理带来的分子和组织学益处。此外 ...